Literature DB >> 26616417

HIV reservoirs: what, where and how to target them.

Melissa J Churchill1, Steven G Deeks2, David M Margolis3, Robert F Siliciano4, Ronald Swanstrom5.   

Abstract

One of the main challenges in the fight against HIV infection is to develop strategies that are able to eliminate the persistent viral reservoir that harbours integrated, replication-competent provirus within host cellular DNA. This reservoir is resistant to antiretroviral therapy (ART) and to clearance by the immune system of the host; viruses originating from this reservoir lead to rebound viraemia once treatment is stopped, giving rise to new rounds of infection. Several studies have focused on elucidating the cells and tissues that harbour persistent virus, the true size of the reservoir and how best to target it, but these topics are the subject of ongoing debate. In this Viewpoint article, several experts in the field discuss the constitution of the viral reservoir, how best to measure it and the best ways to target this source of persistent infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26616417     DOI: 10.1038/nrmicro.2015.5

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  10 in total

1.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.

Authors:  Amanda M Crooks; Rosalie Bateson; Anna B Cope; Noelle P Dahl; Morgan K Griggs; JoAnn D Kuruc; Cynthia L Gay; Joseph J Eron; David M Margolis; Ronald J Bosch; Nancie M Archin
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

2.  Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues.

Authors:  Melissa J Churchill; Paul R Gorry; Daniel Cowley; Luxshimi Lal; Secondo Sonza; Damian F J Purcell; Katherine A Thompson; Dana Gabuzda; Justin C McArthur; Carlos A Pardo; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.

Authors:  Tory P Johnson; Karan Patel; Kory R Johnson; Dragan Maric; Peter A Calabresi; Rodrigo Hasbun; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

4.  An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.

Authors:  Viktor Dahl; Magnus Gisslen; Lars Hagberg; Julia Peterson; Wei Shao; Serena Spudich; Richard W Price; Sarah Palmer
Journal:  J Infect Dis       Date:  2013-12-12       Impact factor: 5.226

5.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

6.  Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia.

Authors:  Melissa J Churchill; Steven L Wesselingh; Daniel Cowley; Carlos A Pardo; Justin C McArthur; Bruce J Brew; Paul R Gorry
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

7.  Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

Authors:  Ana Canestri; François-Xavier Lescure; Stephane Jaureguiberry; Antoine Moulignier; Corinne Amiel; Anne Geneviève Marcelin; Gilles Peytavin; Roland Tubiana; Gilles Pialoux; Christine Katlama
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

8.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.

Authors:  J D Glass; H Fedor; S L Wesselingh; J C McArthur
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

9.  Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.

Authors:  Natalia Soriano-Sarabia; Nancie M Archin; Rosalie Bateson; Noelle P Dahl; Amanda M Crooks; JoAnn D Kuruc; Carolina Garrido; David M Margolis
Journal:  PLoS Pathog       Date:  2015-10-16       Impact factor: 6.823

10.  CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.

Authors:  L R Gray; D Cowley; C Welsh; H K Lu; B J Brew; S R Lewin; S L Wesselingh; P R Gorry; M J Churchill
Journal:  Mol Psychiatry       Date:  2015-08-25       Impact factor: 15.992

  10 in total
  139 in total

1.  Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition.

Authors:  C Paula Lewis-de Los Angeles; Paige L Williams; Yanling Huo; Shirlene D Wang; Kristina A Uban; Megan M Herting; Kathleen Malee; Ram Yogev; John G Csernansky; Sharon Nichols; Russell B Van Dyke; Elizabeth R Sowell; Lei Wang
Journal:  Brain Behav Immun       Date:  2017-01-10       Impact factor: 7.217

2.  Proteomic Profiling of a Primary CD4+ T Cell Model of HIV-1 Latency Identifies Proteins Whose Differential Expression Correlates with Reactivation of Latent HIV-1.

Authors:  Jamaluddin Md Saha; Hongbing Liu; Pei-Wen Hu; Bryan C Nikolai; Hulin Wu; Hongyu Miao; Andrew P Rice
Journal:  AIDS Res Hum Retroviruses       Date:  2017-12-05       Impact factor: 2.205

3.  Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.

Authors:  Nina C Flerin; Ariola Bardhi; Jian Hua Zheng; Maria Korom; Joy Folkvord; Colin Kovacs; Erika Benko; Ronald Truong; Talia Mota; Elizabeth Connick; R Brad Jones; Rebecca M Lynch; Harris Goldstein
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.

Authors:  Stefanie Perez; Ann-Marie Johnson; Shi-Hua Xiang; Jian Li; Brian T Foley; Lara Doyle-Meyers; Antonito Panganiban; Amitinder Kaur; Ronald S Veazey; Yuntao Wu; Binhua Ling
Journal:  J Neurovirol       Date:  2017-11-27       Impact factor: 2.643

6.  Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.

Authors:  Serena Spudich; Kevin R Robertson; Ronald J Bosch; Rajesh T Gandhi; Joshua C Cyktor; Hanna Mar; Bernard J Macatangay; Christina M Lalama; Charles Rinaldo; Ann C Collier; Catherine Godfrey; Joseph J Eron; Deborah McMahon; Jana L Jacobs; Dianna Koontz; Evelyn Hogg; Alyssa Vecchio; John W Mellors
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

7.  A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1 gp160.

Authors:  Rebecca M Lim; Liang Rong; Anjie Zhen; Jianming Xie
Journal:  ACS Chem Biol       Date:  2020-07-28       Impact factor: 5.100

Review 8.  Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

Authors:  Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

9.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

10.  A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.

Authors:  Paige Charlins; Kimberly Schmitt; Leila Remling-Mulder; Louise E Hogan; Emily Hanhauser; Kristen S Hobbs; Frederick Hecht; Steven G Deeks; Timothy J Henrich; Ramesh Akkina
Journal:  Virology       Date:  2017-04-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.